Welcome to our dedicated page for Elutia SEC filings (Ticker: ELUT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Elutia Inc. filings document the regulatory record for a medical technology company developing and commercializing drug-eluting biomatrix products. Form 8-K reports cover financial results, preliminary operating updates, Nasdaq listing notices and compliance events, and material compensation actions tied to the company's Class A common stock.
Proxy materials disclose board matters, executive compensation, equity-award information, shareholder voting items, and governance practices. The filing record also includes disclosures on inducement award plans, stock-based compensation capacity, registered securities on the Nasdaq Capital Market, and emerging growth company status.
Elutia Inc. reported fourth-quarter and full-year 2025 results and highlighted a major strategic shift. Net sales from continuing operations were $3.3M in Q4 2025, up from $2.8M, but full-year 2025 sales declined to $12.3M from $14.5M.
Loss from continuing operations narrowed sharply to $15.9M in 2025 from $45.3M in 2024 as operating expenses fell. Thanks largely to a $88M BioEnvelope divestiture, income from discontinued operations was $69.3M, driving full-year net income of $53.4M versus a $53.9M loss in 2024.
Year-end cash and escrowed proceeds totaled $44.4M, with long-term debt eliminated and stockholders’ equity improving from a deficit of $(46.3M) to positive $27.7M. Elutia submitted its base biologic matrix NXT-41 to the FDA and expects NXT-41 clearance in the second half of 2026 and full NXT-41x clearance in the first half of 2027.
Elutia Inc. adopted a new 2026 Inducement Award Plan to grant equity-based incentives to people who are newly hired by the company or its subsidiaries. The plan is intended to help attract, retain and motivate employees who are expected to make important contributions.
The Inducement Plan allows grants of stock options (excluding incentive stock options), stock appreciation rights, restricted stock, restricted stock units, other stock- or cash-based awards, and dividend equivalents, covering up to 2,000,000 shares of Class A common stock. Awards may only be made as material inducements to employment under Nasdaq Listing Rule 5635(c)(4), so stockholder approval was not required. The Compensation Committee administers the plan, sets vesting and other terms, and may adjust awards in connection with a change in control.
Elutia Inc. has regained full compliance with Nasdaq’s continued listing standards. Nasdaq notified the company that its market value of listed securities was at least $35 million for eleven consecutive business days from January 21, 2026 through February 4, 2026, restoring compliance with Listing Rule 5550(b)(2). A separate Nasdaq notice confirmed that Elutia met the minimum $1.00 bid price requirement for ten consecutive business days from February 13, 2026 through February 27, 2026 under Listing Rule 5550(a)(2). With both matters now closed, Elutia’s Class A common stock will continue trading on the Nasdaq Capital Market under the symbol ELUT.
Alyeska Investment Group and related parties filed an amended Schedule 13G reporting a 3.18% passive ownership stake in Elutia Inc. Class A common stock. They report beneficial ownership of 1,281,172 shares, consisting of 1,000,000 common shares and 281,172 PIPE shares.
The percentage is based on 42,784,848 Elutia common shares outstanding as referenced from a recent Form 10-Q. The filers certify the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of Elutia.
Nantahala Capital Management and its principals report a sizable stake in Elutia Inc. As of December 31, 2025, they may be deemed to beneficially own 4,124,854 shares of Elutia’s Class A common stock, representing 9.99% of the outstanding class.
The position includes 939,907 shares that can be acquired within sixty days through warrant exercises. Nantahala, Wilmot B. Harkey, and Daniel Mack report shared voting and dispositive power over all 4,124,854 shares, with no sole voting or dispositive power. A Nantahala-advised fund, BLACKWELL PARTNERS LLC - SERIES A, has rights to dividends or sale proceeds on more than five percent of the shares reported.
The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Elutia, aside from activities solely in connection with a nomination under Rule 14a-11.
Knollwood Investment Advisory, LLC has filed a Schedule 13G reporting beneficial ownership of 2,556,724 shares of Elutia Inc. Class A Common Stock, representing 6.3% of the class as of 12/31/2025.
Knollwood reports sole voting and sole dispositive power over all 2,556,724 shares, with no shared voting or dispositive power. The firm states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Elutia Inc.
Elutia Inc. insider Kevin L. Rakin and affiliated HighCape entities reported recent share activity in Elutia Class A Common Stock. On January 30, 2026, a reporting person purchased 70,000 shares at a weighted average price of $1.06 per share, with individual trade prices ranging from $1.05 to $1.08. Following this purchase, 196,120 shares were held directly. The filing also reports 322,419 shares held indirectly by trusts and 4,706,559 shares indirectly held through HighCape-related entities, which may be deemed beneficially owned as described in the footnotes, subject to customary beneficial ownership disclaimers.
Elutia Inc. director Guido J. Neels reported an open-market purchase of Class A common stock. On January 30, 2026, he bought 20,000 shares of Elutia at a weighted average price of $1.04 per share, with individual trade prices ranging from $1.03 to $1.07. Following this transaction, he beneficially owned 118,750 shares of Elutia Class A common stock held directly.
Elutia Inc. director Guido J. Neels reported open-market purchases of the company’s Class A common stock on two consecutive days. On January 28, 2026, he bought 15,000 shares at a weighted average price of $1.06, with individual trades ranging from $1.00 to $1.10, bringing his holdings to 83,750 shares.
On January 29, 2026, he purchased another 15,000 shares at a weighted average price of $1.06, from $1.03 to $1.10 per share. After these transactions, Neels directly owned 98,750 Class A common shares of Elutia Inc.
Elutia Inc. (ELUT) received an updated ownership report from AIGH-related entities. AIGH Capital Management LLC, AIGH Investment Partners LLC and Orin Hirschman together report beneficial ownership of 3,068,185 shares of Elutia common stock, representing 7.6% of the class as of the event date.
The filing notes sole voting and dispositive power over these 3,068,185 shares and no shared power. It also states that this percentage excludes warrants to purchase 1,300,000 additional shares that are not currently exercisable because of beneficial ownership limitations. The reporting holders certify the position is held in the ordinary course and not to change or influence control.